Skip to main content
SpringerLink
Log in

Preemptive rituximab puts hold on post-transplant lymphoproliferation

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Carpenter B, Haque T, Dimopoulou M, Atkinson C, Roughton M, Grace S, Denovan S, Fielding A, Kottaridis PD, Griffiths P, Mackinnon S, Emery V, Chakraverty R.Incidence and dynamics of Epstein-Barr Virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation. Transplantation: 16 Jun 2010. Available from: URL: http://dx.doi.org/10.1097/tp.0b013e3181e7a3bf

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preemptive rituximab puts hold on post-transplant lymphoproliferation. React. Wkly. 1312, 4 (2010). https://doi.org/10.2165/00128415-201013120-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013120-00009

Keywords

Search

Navigation